HER-2 L866M
|
CRC
|
HER-2 L866M
|
CRC
|
cetuximab Resistant: D – Preclinical
|
cetuximab Resistant: D – Preclinical
|
HER-2 L866M
|
CRC
|
HER-2 L866M
|
CRC
|
panitumumab Resistant: D – Preclinical
|
panitumumab Resistant: D – Preclinical
|